Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Renvatinib
Hepatocellular Carcinoma
First Affiliated Hospital of Guangxi Medical UniversityP1/2CCC (48)
Renvatinib
Portal Vein Thrombosis
First Affiliated Hospital of Guangxi Medical UniversityP1/2CCC (48)
Repotrectinib
Central Nervous System Neoplasm
Turning Point Therapeutics, Inc.P1/2CCC (48)
Retifanlimab
Anaplastic Oligodendroglioma
Mayo ClinicP1/2CCC (48)
Retifanlimab
Astrocytoma, IDH-Mutant, Grade 3
Mayo ClinicP1/2CCC (48)
Retifanlimab
Colorectal Cancer
National Cancer Institute (NCI)P1/2CCC (48)
Retifanlimab
Diffuse Astrocytoma
Mayo ClinicP1/2CCC (48)
Retifanlimab
Diffuse Large B-Cell Lymphoma
University of Alabama at BirminghamP1/2CCC (48)
Retlirafusp Alfa
Hodgkins Lymphoma
Chinese PLA General HospitalP1/2CCC (48)
Revumenib
Acute Leukemia
Memorial Sloan Kettering Cancer CenterP1/2CCC (48)
Rezatapopt
Hormone Receptor-Positive Breast Cancer
PMV Pharmaceuticals, IncP1/2CCC (48)
Rezatapopt
HER2 Positive Breast Carcinoma
PMV Pharmaceuticals, IncP1/2CCC (48)
Rezatapopt
Neoplasm
PMV Pharmaceuticals, IncP1/2CCC (48)
Rhenium Liposome Treatment
Glioma
Plus TherapeuticsP1/2CCC (48)
Rifaximin
Bladder Transitional Cell Carcinoma
Mansoura UniversityP1/2CCC (48)
Rifaximin
Vascular Dementia
Jasmohan BajajP1/2CCC (48)
Rifaximin
Radiation-Induced Disorder
Mansoura UniversityP1/2CCC (48)
Rilvegostomig
Skin Squamous Cell Carcinoma
AstraZenecaP1/2CCC (48)
Rilvegostomig
Squamous Cell Lung Carcinoma
AstraZenecaP1/2CCC (48)
Rituximab
Diamond-Blackfan Anemia
Paul SzabolcsP1/2CCC (48)
Rituximab
Chronic Obstructive Pulmonary Disease
Paul SzabolcsP1/2CCC (48)
Rituximab
EZB-MYC+ Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP1/2CCC (48)
Rituximab
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
M.D. Anderson Cancer CenterP1/2CCC (48)
Rmc-6236
Colorectal Cancer
Revolution Medicines, Inc.P1/2CCC (48)
Rmc-6236
Lung Cancer
Tango Therapeutics, Inc.P1/2CCC (48)
Showing 1726 to 1750 of 6,308 assets
PreviousPage 70 of 253Next